Cypress Wealth Services LLC boosted its position in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 4.3% in the fourth quarter, ...

Fermata Advisors LLC lifted its position in Amazon.com, Inc. (NASDAQ:AMZN) by 3.2% in the 4th quarter, HoldingsChannel.com ...

Beta Bionics hit net sales of $44.7m in the first nine months of 2024, marking an increase from $3.6m in 2023. Beta Bionics’ ...

Edge Wealth Management LLC lowered its stake in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 3.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities ...

The company previously announced unaudited preliminary fourth quarter net sales between $45.1 million to $46.6 million and full year 2024 preliminary unaudited net sales projected to range ...

About This EventBeta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the design, development of advanced diabetes management solutions, visits the Nasdaq MarketSite in Times Square.In honor of ...

Stock futures edged higher Thursday night as investors analyzed earnings reports from Apple and other well-known companies ...

Thursday's coverage included more tech earnings, focus on Trump's latest on potential tariffs and more analysis around Monday ...

Wall Street's major averages notice limited moves on Thursday, as the Q4 GDP growth came in weaker than expected, while investors digested the tech earnings.

All three major U.S. stock indexes were higher in late-afternoon trade as focused turned away from Wednesday's Federal Reserve meeting and toward corporate earnings on deck. The S&P 500 index was ...

On earnings calls this week, several technology giants pointed to DeepSeek's software having "clever tricks," while also raising questions about the security and effectiveness of the Chinese-based ...

The Warren-headquartered clinical-stage specialty immunotherapy biotechnology company focuses on the development of T-cell ...